Skip to content
healthcare.dev

TIAGABINE HYDROCHLORIDE

NDC 62756-200, TIAGABINE HYDROCHLORIDE, tablet, film coated, from Sun Pharmaceutical Industries, Inc..

Product NDC
62756-200
Status
Listed
Labeler
Sun Pharmaceutical Industries, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077555
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62756-200 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TIAGABINE HYDROCHLORIDE2 mg/1

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
62756-200-18627560200181000 TABLET, FILM COATED in 1 BOTTLE (62756-200-18)
62756-200-836275602008330 TABLET, FILM COATED in 1 BOTTLE (62756-200-83)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7eeb2d81-c5d7-46a0-aa5c-149b55df71bd

Use it

Look up 62756-200 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62756-200 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62756-200. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.